|Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report|
AJ Rush, MH Trivedi, SR Wisniewski, AA Nierenberg, JW Stewart, ...
American Journal of Psychiatry 163 (11), 1905-1917, 2006
|Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice|
MH Trivedi, AJ Rush, SR Wisniewski, AA Nierenberg, D Warden, L Ritz, ...
American journal of Psychiatry 163 (1), 28-40, 2006
|Diagnosis and definition of treatment-resistant depression|
Biological psychiatry 53 (8), 649-659, 2003
|Medication augmentation after the failure of SSRIs for depression|
MH Trivedi, M Fava, SR Wisniewski, ME Thase, F Quitkin, D Warden, ...
New England Journal of Medicine 354 (12), 1243-1252, 2006
|Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression|
AJ Rush, MH Trivedi, SR Wisniewski, JW Stewart, AA Nierenberg, ...
New England Journal of Medicine 354 (12), 1231-1242, 2006
|A mega-analysis of genome-wide association studies for major depressive disorder|
S Ripke, NR Wray, CM Lewis, SP Hamilton, MM Weissman, G Breen, ...
Molecular psychiatry 18 (4), 497, 2013
|Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design|
AJ Rush, M Fava, SR Wisniewski, PW Lavori, MH Trivedi, HA Sackeim, ...
Controlled clinical trials 25 (1), 119-142, 2004
|Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder|
DA Pizzagalli, AJ Holmes, DG Dillon, EL Goetz, JL Birk, R Bogdan, ...
American Journal of Psychiatry 166 (6), 702-710, 2009
|Definition and epidemiology of treatment-resistant depression|
M Fava, KG Davidson
Psychiatric Clinics of North America 19 (2), 179-200, 1996
|Remissions in maternal depression and child psychopathology: a STAR* D-child report|
MM Weissman, DJ Pilowsky, PJ Wickramaratne, A Talati, SR Wisniewski, ...
Jama 295 (12), 1389-1398, 2006
|Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR* D report|
M Fava, AJ Rush, JE Alpert, GK Balasubramani, SR Wisniewski, ...
American Journal of Psychiatry 165 (3), 342-351, 2008
|Depression and public health: an overview|
P Cassano, M Fava
Journal of psychosomatic research 53 (4), 849-857, 2002
|Major depressive disorder|
M Fava, KS Kendler
Neuron 28 (2), 335-341, 2000
|Report by the ACNP Task Force on response and remission in major depressive disorder|
AJ Rush, HC Kraemer, HA Sackeim, M Fava, MH Trivedi, E Frank, ...
Neuropsychopharmacology 31 (9), 1841-1853, 2006
|Background and rationale for the sequenced treatment alternatives to relieve depression (STAR* D) study.|
M Fava, AJ Rush, MH Trivedi, AA Nierenberg, ME Thase, HA Sackeim, ...
Psychiatric Clinics of North America, 2003
|Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial|
JF Rosenbaum, M Fava, SL Hoog, RC Ascroft, WB Krebs
Biological psychiatry 44 (2), 77-87, 1998
|The STAR* D Project results: a comprehensive review of findings|
D Warden, AJ Rush, MH Trivedi, M Fava, SR Wisniewski
Current psychiatry reports 9 (6), 449-459, 2007
|Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task|
DA Pizzagalli, D Iosifescu, LA Hallett, KG Ratner, M Fava
Journal of psychiatric research 43 (1), 76-87, 2008
|STAR* D: what have we learned?|
American Journal of Psychiatry 164 (2), 201-204, 2007
|Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)|
GS Sachs, ME Thase, MW Otto, M Bauer, D Miklowitz, SR Wisniewski, ...
Biological psychiatry 53 (11), 1028-1042, 2003